Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient ...

The French drugmaker on Monday announced progress on a deal to sell 50% of its over-the-counter division to Clayton Dubilier ...

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

Sanofi and CD&R have entered exclusive negotiations for CD&R to acquire a 50% controlling stake in Opella, Sanofi’s consumer ...

The French government has taken a small stake in Sanofi's consumer healthcare business Opella, following political backlash ...

Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the ...

Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, ...

Sanofi and Sudair Pharma Company (SPC) have joined forces to establish a state-of-the-art manufacturing facility within the ...

By deploying relatable imagery of princesses pooping, Dulcolax has set out to challenge societal norms that teach girls to be ashamed of bodily functions.